Desvenlafaxine vs. Desvenlafaxine Succinate: No Clinical Difference
There is no clinical difference between "desvenlafaxine" and "desvenlafaxine succinate"—they refer to the same medication. Desvenlafaxine succinate is simply the chemical salt form (succinate monohydrate) of the active drug desvenlafaxine, and this is the formulation used in all commercially available products 1, 2.
Chemical Formulation Details
The FDA-approved medication contains desvenlafaxine succinate monohydrate as the active pharmaceutical ingredient 1, 2. The terminology works as follows:
- Desvenlafaxine (free base): C16H25NO2 with molecular weight 263
- Desvenlafaxine succinate monohydrate: C16H25NO2•C4H6O4•H2O with molecular weight 399.48 1, 2
The succinate salt form is used because it provides better water solubility and pharmaceutical stability compared to the free base 3. When you see tablet strengths listed (25 mg, 50 mg, or 100 mg), these refer to the amount of active desvenlafaxine, not the total weight of the succinate salt 1, 2.
Practical Prescribing Implications
When prescribing or dispensing, use either term interchangeably—the pharmacy will provide the same product regardless of whether you write "desvenlafaxine" or "desvenlafaxine succinate" 1, 2. The extended-release tablets contain:
- 38 mg desvenlafaxine succinate = 25 mg desvenlafaxine
- 76 mg desvenlafaxine succinate = 50 mg desvenlafaxine
- 152 mg desvenlafaxine succinate = 100 mg desvenlafaxine 1, 2
All dosing recommendations in clinical practice refer to the active desvenlafaxine content (50-100 mg daily range for major depressive disorder), not the succinate salt weight 4, 5, 6.
Why the Succinate Salt Matters Pharmaceutically
The succinate salt formulation creates a very strong hydrogen-bonding network that contributes to thermal stability—desolvation and melting occur together at approximately 402 K (129°C) 3. This pharmaceutical property ensures consistent drug delivery in the extended-release formulation but has no impact on clinical decision-making or patient outcomes.